Literature DB >> 12154098

Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.

Chiara Luberto1, Daniel F Hassler, Paola Signorelli, Yasuo Okamoto, Hirofumi Sawai, Eric Boros, Debra J Hazen-Martin, Lina M Obeid, Yusuf A Hannun, Gary K Smith.   

Abstract

A high throughput screen for neutral, magnesium-dependent sphingomyelinase (SMase) was performed. One inhibitor discovered in the screen, GW4869, functioned as a noncompetitive inhibitor of the enzyme in vitro with an IC(50) of 1 microm. It did not inhibit acid SMase at up to at least 150 microm. The compound was then evaluated for its ability to inhibit tumor necrosis factor (TNF)-induced activation of neutral SMase (N-SMase) in MCF7 cells. GW4869 (10 microm) partially inhibited TNF-induced sphingomyelin (SM) hydrolysis, and 20 microm of the compound was protected completely from the loss of SM. The addition of 10-20 microm GW4869 completely inhibited the initial accumulation of ceramide, whereas this effect was partially lost at later time points (24 h). These data therefore support the inhibitory action of GW4869 on N-SMase not only in vitro but also in a cellular model. The addition of GW4869 at both 10 and 20 microm did not modify cellular glutathione levels in response to TNF, suggesting that the action of GW4869 occurred downstream of the drop in glutathione, which was shown previously to occur upstream of the activation of N-SMase. Further, whereas TNF treatment also caused a 75% increase of de novo synthesized ceramide after 20 h of incubation, GW4869, at either 10 or 20 microm, had no effect on this pathway of ceramide generation. In addition, GW4869 did not significantly impair TNF-induced NF-kappaB translocation to nuclei. Therefore, GW4869 does not interfere with other key TNF-mediated signaling effects. GW4869 was able, in a dose-dependent manner, to significantly protect from cell death as measured by nuclear condensation, caspase activation, PARP degradation, and trypan blue uptake. These protective effects were accompanied by significant inhibition of cytochrome c release from mitochondria and caspase 9 activation, therefore localizing N-SMase activation upstream of mitochondrial dysfunction. In conclusion, our results indicate that N-SMase activation is a necessary step for the full development of the cytotoxic program induced by TNF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154098     DOI: 10.1074/jbc.M206747200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  118 in total

1.  Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α.

Authors:  Brian M Barth; Sally J Gustafson; Thomas B Kuhn
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

2.  Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

3.  Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.

Authors:  María José Hernández-Corbacho; Daniel Canals; Mohamad M Adada; Mengling Liu; Can E Senkal; Jae Kyo Yi; Cungui Mao; Chiara Luberto; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2015-08-28       Impact factor: 5.157

Review 4.  The mechanism of necroptosis in normal and cancer cells.

Authors:  Simone Fulda
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

5.  A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria.

Authors:  Helene Birbes; Chiara Luberto; Yi-Te Hsu; Samer El Bawab; Yusuf A Hannun; Lina M Obeid
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

Review 6.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

Review 7.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

Review 8.  Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.

Authors:  Michael B Dinkins; Guanghu Wang; Erhard Bieberich
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw.

Authors:  A Khodorova; G D Nicol; G Strichartz
Journal:  Neuroscience       Date:  2013-10-01       Impact factor: 3.590

10.  Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction.

Authors:  Philip D Coblentz; Bumsoo Ahn; Linda F Hayward; Jeung-Ki Yoo; Demetra D Christou; Leonardo F Ferreira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.